Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1994-07-22
1996-04-16
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424493, 424479, 424480, 424472, 514869, A61K 916
Patent
active
055080448
ABSTRACT:
A solid oral dosage form comprising diltiazem (or a pharmaceutically acceptable salt thereof) in controlled release form and hydrochlorothiazide in immediate release form. Preferably, the controlled release component comprises a plurality of spheroids comprising diltiazem and a spheronizing agent.
REFERENCES:
patent: 4728512 (1988-03-01), Mehta et al.
patent: 4891230 (1990-01-01), Geoghegan et al.
patent: 5156850 (1992-10-01), Wong et al.
patent: 5286497 (1994-02-01), Hendrickson et al.
Buris et al. JAMA 3/90 vol. 263 #11, pp. 1507-1512 An Assessment of Dictiazem and Hydrochlorothiazide in Hypertension.
Weinstock Chem Abstracts 117(18) 178319h Antihypertension Compositions Containing Diuretics and Angioprosin II Receptor Antagonists.
"Diuretics Versus Calcium-Channel Blockers in Systemic Hypertension: A Preliminary Multicenter Experience with Hydrochlorothiazide and Sustained-Release Diltiazem", Frishman, et al., American Journal of Cardiology, Dec. 6, 1985, vol. 56, pp. 92H-96H.
"An Assessment of Diltiazem and Hydrochlorothiazide in Hypertension" Buris, et al., JAMA, Mar. 16, 1990, vol. 263 No. 11; pp. 1507-1512.
"A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension", Weir, et al. Journal of Human Hypertension (1992) vol. 6 pp. 133-138.
"Comparison of Hydrochlorothiazide and Sustained-Release Diltiaze for Mild-to-Moderate Systemic Hypertension", Frishman, et al, American Journal of Cardiol Mar. 1, 1987, vol. 59, pp. 615-623.
Brown Adrian
Buxton Ian R.
Critchley Helen
Leslie Stewart T.
Malkowska Sandra T. A.
Euro-Celtique S.A.
Levy N.
Page Thurman K.
LandOfFree
Diltiazem pharmaceutical spheroid formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diltiazem pharmaceutical spheroid formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diltiazem pharmaceutical spheroid formulation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-323681